Ulster University Reports Findings in Personalized Medicine (Computational appro aches for clinical, genomic and proteomic markers of response to glucagon-like p eptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machi ne …)

Robotics & Machine Learning Daily News2024，Issue(Aug.12) ：91-92.

来源：

NETL
NSTL

Ulster University Reports Findings in Personalized Medicine (Computational appro aches for clinical, genomic and proteomic markers of response to glucagon-like p eptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machi ne …)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews – New research on Drugs and Therapies - Personalize d Medicine is the subject of a report. Accordingto news reporting originating i n Londonderry, United Kingdom, by NewsRx journalists, research stated,“In 2021, the International Diabetes Federation reported that 537 million people worldwid e are living withdiabetes. While glucagon-like peptide-1 agonists provide signi ficant benefits in diabetes management,approximately 40 % of pati ents do not respond well to this therapy.”

Key words

Londonderry/United Kingdom/Europe/Alg orithms/Biomarkers/Cyborgs/Diabetes Mellitus/Diagnostics and Screening/Drug s and Therapies/Emerging Technologies/Endocrine System Diseases and Conditions/Endocrinology/Gastrointestinal Hormones/Genet

引用本文复制引用

出版年

2024

Robotics & Machine Learning Daily News

ISSN：

段落导航